A clinical trial of Deep IL-12 primed T cells
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2019
Price : $35 *
At a glance
- Drugs TRQ 1201 (Primary)
- Indications Cancer; Haematological malignancies; Solid tumours
- Focus Adverse reactions
- 08 Nov 2019 According to an Torque Therapeutics media release, the company is preparing to move into clinical trials in the latter part of 2019 and in 2020.
- 29 Nov 2018 New trial record
- 12 Nov 2018 According to a Torque Therapeutics media release, the company preparing to move into clinical trials in 2019.